Camber Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-450,000
| Closed | -$98.8M | – | 44 |
|
|
2021
Q4 | $98.8M | Buy |
+450,000
| New | +$98.8M | 3.4% | 9 |
|
|
2017
Q3 | – | Sell |
-350,000
| Closed | -$45.1M | – | 28 |
|
|
2017
Q2 | $45.1M | Sell |
350,000
-300,000
| -46% | -$38.7M | 2.2% | 13 |
|
|
2017
Q1 | $71.1M | Sell |
650,000
-100,000
| -13% | -$10.9M | 2.88% | 9 |
|
|
2016
Q4 | $55.3M | Buy |
+750,000
| New | +$55.3M | 2.88% | 14 |
|
|
2014
Q4 | – | Sell |
-400,000
| Closed | -$44.9M | – | 42 |
|
|
2014
Q3 | $44.9M | Buy |
+400,000
| New | +$44.9M | 4.22% | 10 |
|